In two cohorts of Nordic APS1 patients, we have now shown almost 100% prevalences of very high titre IgG neutralising autoantibodies against most IFN-α subtypes and against the related, but antigenically distinct, IFN-ω. This evidence concerns the gene IFNA1 and autoimmune polyendocrine syndrome type 1.